Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 814, Issue 2, 2005, Pages 217-223

  Migliorança, Luis H ^a,b   Barrientos Astigarraga, Rafael E ^c   Schug, B S ^d   Blume, H H ^d   Pereira, Alberto S ^a   De Nucci, Gilberto ^a,b,c,e  

^a Galeno Research Unit   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SocraTec R and D GmbH   (Germany)

^e Jesuino Marcondes Machado   (Brazil)

Author keywords

Antihipertensive; Bioequivalence; Felodipine; Heathy volunteer; LC MS MS

Indexed keywords

BLOOD PLASMA; FELODIPINE; HUMAN PLASMA; NIMODIPINE;

BLOOD; CONCENTRATION (PROCESS); ETHERS; EXTRACTION; MASS SPECTROMETRY; QUALITY CONTROL;

LIQUID CHROMATOGRAPHY;

FELODIPINE; NIMODIPINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); ELUTION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

CALCIUM CHANNEL BLOCKERS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FELODIPINE; HUMANS; MASS SPECTROMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 11844284835     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.10.032     Document Type: Article

References (20)

1. A. Vuylsteke, Q. Milner, H. Ericsson, D. Mur, J. Dunning, Å. Jolin-Mellgård, M. Nordlander, and R. Latimer Br. J. Anaesth. 85 2000 683
2. E. Saltiel, A.G. Ellrodt, J.P. Monk, and M.S. Langley Drugs 36 1988 387
3. N.E. Azie, D.C. Brater, P.A. Becker, D.R. Jones, and S.D. Hall Clin. Pharmacol. Ther. 64 1998 369
4. R. Nishioka, I. Umeda, N. Oi, S. Tabata, and K. Uno J. Chromatogr. 565 1991 237
5. P.A. Soons, M.C. Roosemalen, and D.D. Breimer J. Chromatogr. 528 1990 343
6. M. Ahnoff, M. Ervik, and L. Johansson J. Chromatogr. 394 1987 419
7. J.A. Lopez, V. Martinez, R.M. Alonso, and R.M. Jimenez J. Chromatogr. A 870 2000 105
8. Y. Tokuma, T. Fujiwara, and H. Noghuchi Biomed. Environ Mass Spectrom. 13 1986 251
9. Y.P. Patel, S. Patil, I.C. Bhoir, and M. Sundarresan J. Chromatogr. A 828 1998 283
10. R.M. Cardoza, and P.D. Amin J. Pharm. Biomed. Anal. 27 2002 711
11. J.D. Dru, J.Y. Hsieh, B.K. Matuszewski, and M.R. Dobrinska J. Chromatogr. B 666 1995 259
12. H.H. Maurer, and J.W. Arlt J. Anal. Toxicol. 23 1999 73
13. M. Ahnoff, and B.A. Persson J. Chromatogr. 531 1990 181
14. B. Lindmark, M. Ahnoff, and B.A. Persson J. Pharm. Biomed. Anal. 27 2002 489
15. H. Kim, H. Roh, S.B. Yeom, H.J. Lee, and S.B. Han Chromatographia 58 2003 235
16. W. Muck Pharmazie 54 1999 639
17. R. Kostiainen, T. Kotiaho, T. Kuuranne, and S. Auriola J. Mass Spectrom. 38 2003 357
18. R. Bonfiglio, R.C. King, T.V. Olah, and K. Merckle Rapid Commun. Mass Spectrom. 13 1999 1175
19. Federal Register Part 320: Bioavailability and Bioequivalence Requirements, Food and Drug Administration, Washington, DC, 1985, p. 154.
20. Food and Drug Administration, Pharmacopeial Forum 19 (1993) 6501.